234 related articles for article (PubMed ID: 21513699)
1. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins.
Zoabi M; Sadeh R; de Bie P; Marquez VE; Ciechanover A
Biochem Biophys Res Commun; 2011 May; 408(3):393-8. PubMed ID: 21513699
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.
Choudhury SR; Balasubramanian S; Chew YC; Han B; Marquez VE; Eckert RL
Carcinogenesis; 2011 Oct; 32(10):1525-32. PubMed ID: 21798853
[TBL] [Abstract][Full Text] [Related]
3. The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.
Zhou J; Bi C; Cheong LL; Mahara S; Liu SC; Tay KG; Koh TL; Yu Q; Chng WJ
Blood; 2011 Sep; 118(10):2830-9. PubMed ID: 21734239
[TBL] [Abstract][Full Text] [Related]
4. Role of histone H2A ubiquitination in Polycomb silencing.
Wang H; Wang L; Erdjument-Bromage H; Vidal M; Tempst P; Jones RS; Zhang Y
Nature; 2004 Oct; 431(7010):873-8. PubMed ID: 15386022
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional repression by NIPP1 is mediated by Polycomb group proteins.
Roy N; Van Eynde A; Beke L; Nuytten M; Bollen M
Biochim Biophys Acta; 2007; 1769(9-10):541-5. PubMed ID: 17804093
[TBL] [Abstract][Full Text] [Related]
7. The polycomb repressive complex 2 is a potential target of SUMO modifications.
Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
[TBL] [Abstract][Full Text] [Related]
8. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
[TBL] [Abstract][Full Text] [Related]
9. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
O'Meara MM; Simon JA
Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
[TBL] [Abstract][Full Text] [Related]
10. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing.
Schoeftner S; Sengupta AK; Kubicek S; Mechtler K; Spahn L; Koseki H; Jenuwein T; Wutz A
EMBO J; 2006 Jul; 25(13):3110-22. PubMed ID: 16763550
[TBL] [Abstract][Full Text] [Related]
12. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
[TBL] [Abstract][Full Text] [Related]
13. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
[TBL] [Abstract][Full Text] [Related]
14. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
[TBL] [Abstract][Full Text] [Related]
15. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.
Pasini D; Bracken AP; Jensen MR; Lazzerini Denchi E; Helin K
EMBO J; 2004 Oct; 23(20):4061-71. PubMed ID: 15385962
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
[TBL] [Abstract][Full Text] [Related]
17. Aberrations of EZH2 in cancer.
Chase A; Cross NC
Clin Cancer Res; 2011 May; 17(9):2613-8. PubMed ID: 21367748
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.
Boulay G; Dubuissez M; Van Rechem C; Forget A; Helin K; Ayrault O; Leprince D
J Biol Chem; 2012 Mar; 287(13):10509-10524. PubMed ID: 22315224
[TBL] [Abstract][Full Text] [Related]
19. The central role of EED in the orchestration of polycomb group complexes.
Cao Q; Wang X; Zhao M; Yang R; Malik R; Qiao Y; Poliakov A; Yocum AK; Li Y; Chen W; Cao X; Jiang X; Dahiya A; Harris C; Feng FY; Kalantry S; Qin ZS; Dhanasekaran SM; Chinnaiyan AM
Nat Commun; 2014; 5():3127. PubMed ID: 24457600
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.
Tan J; Yang X; Zhuang L; Jiang X; Chen W; Lee PL; Karuturi RK; Tan PB; Liu ET; Yu Q
Genes Dev; 2007 May; 21(9):1050-63. PubMed ID: 17437993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]